Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis in patients with transthyretin amyloid polyneuropathy

Overview of attention for article published in Orphanet Journal of Rare Diseases, December 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

So far, Altmetric has seen 1 news story.

Early diagnosis and prompt treatment with Vyndaqel (tafamidis) may help halt neurological disease progression in familial…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.